<DOC>
	<DOCNO>NCT02066012</DOCNO>
	<brief_summary>Dysmetabolic iron overload syndrome ( DIOS ) , frequent hepatic iron overload associate metabolic syndrome . We hypothesize mild iron overload induce increase macrophagic polarization towards inflammatory type , thereby contribute cardiovascular risk . Our main objective highlight influence iron overload polarization capacity monocytes alternative macrophage ( call M2 ) . We therefore compare phenotypic marker monocytes/macrophages subject DIOS , metabolic syndrome without iron overload lean subject .</brief_summary>
	<brief_title>MEPHISTO ( Macrophage Phenotype In Metabolic Syndrome With Iron Overload )</brief_title>
	<detailed_description>MEPHISTO pathophysiological , transverse , case-control , single-center study ( university hospital , Clermont-Ferrand , France ) . No intervention ( drug nutritional ) conduct part study participant subject exclusion period . Our objective investigate effect iron overload monocyte/macrophage polarization relation cardiovascular risk factor . We study 60 subject divide 3 group 20 participant : - group DIOS compose subject dysmetabolic hepatosiderosis - group M compose subject metabolic syndrom without iron overload - group T compose lean subject DIOS group participant select among patient recently diagnose DIOS , without secondary hyperferritinemia hepatic iron overload prove liver MRI . Recruitement group DIOS carry internal medicine service . Subjects group M DIOS come file volunteer center clinical investigation ( CIC-501 , Clermont-Ferrand ) . Subject group M group DIOS match age , gender ( +/- 5 kg/m² ) BMI . Subjects group T group DIOS match age gender . As direct benefit expect participant , receive lump sum compensation 50 euro . Each participant undergo 1 hour consultation include clinical examination blood sample . We focus clinical parameter metabolic syndrome ( waist size , BMI , blood pressure ) seek exclusion factor ( infection , neoplasia , anti-inflammatory drug ) . Due potential influence inflammation oxidant stress , factor , smoke exclude . Blood sample use perform : - classical laboratory test ( blood count , reticulocytes , ASAT , ALAT , LDH , lipid profile , glycemia , insulinemia , TSH , , vitamin D , ferritin , transferrin saturation , CRP ) , - specific dosage ( IL-6 , TNFalpha , hepcidine ) ELISA , - monocyte phenotype ( CD14 , CD16 , CD 163 , MR ) FACS ( Fluorescence Activated Cell Sorting ) , - measurement gene expression monocyte macrophage culture real-time PCR . Our main analysis focus ex vivo polarization monocyte alternative macrophage ( M2 ) phenotypic characterization . Before culture monocyte ( induce M2 macrophage ) without IL-4 ( induce resident macrophage ) , measure expression phenotypic marker polarization ( MR , CD200R , F13A1 , CD163 , AMAC1 , TGFb ) , inflammatory marker ( TNFα , MCP- 1 , IL-6 ) , oxidative stress marker ( HO- 1 ) , marker iron metabolism ( ferroportin , ferritin , hepcidin ) . We use quantitative PCR microfluidic card ( TLDA , Taqman Low-Density Array ) measure gene expression monocytes type M2 macrophage . This technique allow screen expression 24 gene . Different phase require : RNA extraction ( RNeasy kit , Qiagen ) , reverse transcription ( RT-PCR kit , HighCap cDNA RT kit , Applied Biosystems ) , amplification ( TaqMan Fast Advanced Master Mix , Applied Biosystems ) , finally study gene expression ( MFC TaqMan Array GeneEx , Format 24 , Applied Biosystems ) . Our main outcome capacity polarization M2 macrophage evidence expression MR , CD200R , F13A1 , CD163 , AMAC1 , TGFb . Evaluating influence iron overload data clinical examination , result standard biology monocyte gene expression secondary outcome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>• 18 year old write consent group M HSD least one criterion metabolic syndrome definition accord International Diabetes Federation group M hepatic iron overload mesured IRM ( 50 µmol/g ) hyperferritnemia 450 1500 µg/l group T BMI &lt; 25 kg/m² Waist size &lt; 80 cm woman &lt; 94 cm men person guardianship pregnancy active smoking current inflammatory cancerous disease hereditary hemochromatosis use antiinflammatory , immunosuppressive hypoglycaemic drug hemolysis alcool consumption 14 dos woman 21 dos men per week history therapeutic phlebotomy inflammatory syndrome CRP 15 mg/l</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Dysmetabolic Iron Overload Syndrome</keyword>
	<keyword>Metabolic Syndrome X</keyword>
	<keyword>Iron</keyword>
	<keyword>Monocyte</keyword>
	<keyword>Macrophage</keyword>
	<keyword>Polarization</keyword>
</DOC>